Autoimmune Hepatitis Market Size

Market Size in USD Mn

CAGR5.8%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	5.8%
Market Concentration	High
Major Players	Novartis, Gilead Sciences, Pfizer, Merck & Co., Bristol-Myers Squibb and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Autoimmune Hepatitis Market Analysis

The autoimmune hepatitis market is estimated to be valued at USD 134.7 Mn in 2025 and is expected to reach USD 199.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032. The growing prevalence of autoimmune hepatitis across the globe is the major factor driving the growth of the market. According to recent studies, autoimmune hepatitis affected approximately 20-50 individuals per million worldwide.